Methodological issues in the economic analysis of cancer treatments.
about
A review and comparison of methods for recreating individual patient data from published Kaplan-Meier survival curves for economic evaluations: a simulation study.Intent-to-treat analysis in the presence of off-treatment or missing data.Estimation of Survival Probabilities for Use in Cost-effectiveness Analyses: A Comparison of a Multi-state Modeling Survival Analysis Approach with Partitioned Survival and Markov Decision-Analytic ModelingAssessing methods for dealing with treatment switching in randomised controlled trials: a simulation study.Current challenges in health economic modeling of cancer therapies: a research inquiry.Improved curve fits to summary survival data: application to economic evaluation of health technologies.Survival analysis for economic evaluations alongside clinical trials--extrapolation with patient-level data: inconsistencies, limitations, and a practical guide.Adjusting for treatment switching in the METRIC study shows further improved overall survival with trametinib compared with chemotherapy.Surrogate outcomes: experiences at the Common Drug Review.Are adverse effects incorporated in economic models? A survey of current practice.Overview of parametric survival analysis for health-economic applications.Are the true impacts of adverse events considered in economic models of antineoplastic drugs? A systematic review.Validation of surrogate endpoints in advanced solid tumors: systematic review of statistical methods, results, and implications for policy makers.Synthesis of survival and disease progression outcomes for health technology assessment of cancer therapies.Impact of Adverse Events on Health Utility and Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer: Results from the SELECT BC Study.Cost-utility estimation of surgical treatment of pancreatic carcinoma aimed at cure.Economic Evaluation of Fulvestrant 500 mg Compared to Generic Aromatase Inhibitors in Patients with Advanced Breast Cancer in Sweden.Adjusting for treatment switching in randomised controlled trials - A simulation study and a simplified two-stage method.Cautions regarding the fitting and interpretation of survival curves: examples from NICE single technology appraisals of drugs for cancer.Estimating the loss in expectation of life due to cancer using flexible parametric survival modelsComparison of the flexible parametric survival model and Cox model in estimating Markov transition probabilities using real-world dataThe Economic Attractiveness of Targeted Radiotherapy: Value for Money?
P2860
Q30914917-AF97EEA9-093D-45F2-8B53-9C7EAF3B5217Q33536518-ED239445-A831-41B7-BEF7-F26E73415C9CQ33656740-8E9FE660-53C3-40F2-9928-294D1A99B42BQ33790415-729A018F-743E-4B9E-8BA4-5916DBF9246CQ33805471-D7E2CC2A-3326-450E-96EA-C2B50C914C2CQ34045267-93A43D72-CF04-4FAE-A234-E7A3720F6C3CQ34557762-9E880B21-A16D-4FAC-993A-DE10309292C0Q36895055-0395CF83-9C68-4E11-A652-5A888253E40CQ37400903-42E7E9A3-C8ED-4B9C-BB23-C251810ECCC6Q37768240-686CE3E9-CAEF-49AA-82E5-18251E1155BDQ38106867-AAFD5A46-830B-4D0E-99BE-6CBD8FA8B742Q38152967-F9BF209B-646D-4383-BA03-EB84F4306EECQ38259501-966AA57E-62FC-4E23-968B-B07197C9B578Q38523764-94B2F3EF-4C13-4915-913B-9179C8F3D19BQ42697630-F357E5DF-B0AD-4599-A33B-CE6BF5788649Q48737245-BCBDD958-AC8A-4A72-8C01-1574460304DEQ50020933-2B8E03F5-0CDA-4FC1-8DCE-3C1594131C32Q51008987-98CA263D-A9E2-4BE6-B9C7-AE857C90DBC0Q51020348-F0853EC9-23BC-4C02-A3AF-2113A795A265Q57199775-3771E9C1-BD86-4503-AE7D-E7C07B84D5D0Q58723599-8380BAAA-E7E3-4951-8888-8EF06A37CFB5Q58758454-CB2B0A49-6FCD-46B6-959A-8B99EEE2317E
P2860
Methodological issues in the economic analysis of cancer treatments.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Methodological issues in the economic analysis of cancer treatments.
@ast
Methodological issues in the economic analysis of cancer treatments.
@en
type
label
Methodological issues in the economic analysis of cancer treatments.
@ast
Methodological issues in the economic analysis of cancer treatments.
@en
prefLabel
Methodological issues in the economic analysis of cancer treatments.
@ast
Methodological issues in the economic analysis of cancer treatments.
@en
P2093
P1476
Methodological issues in the economic analysis of cancer treatments.
@en
P2093
Jim Chilcott
Paul Tappenden
Silvia Hummel
Simon Eggington
P304
P356
10.1016/J.EJCA.2006.08.010
P577
2006-10-04T00:00:00Z